Macaulay Capital PLC - Investment Update
Announcement provided by
Macaulay Capital PLC · MCAP28/10/2024 07:00
Macaulay Capital PLC
28 October 2024
Macaulay Capital PLC
("Macaulay Capital" or the "Company")
Investment Update
Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces an update regarding one of its investments, Vale Foods (Holdings) Limited ("Vale Foods"), and a loan to a portfolio company.
Repayment of loan and further investment in Vale Foods
Vale Foods, together with its trading subsidiary, is an established food manufacturing business and was the subject of the Company's first investment, undertaken in May 2022.
In 2023, Vale Foods moved to new premises to accommodate increased demand for its products, which required debt finance of
On 16 October 2024, Vale Foods repaid the loan, together with associated interest.
At the same time, Vale Foods raised
Of the new funds raised, the Company (through its wholly owned subsidiary, Macaulay Management Limited) has invested
Macaulay charged an arrangement fee for its assistance with the fund raising.
Loan to portfolio company
The Company also announces that on 25 October 2024, it lent one of the Company's portfolio companies
The Directors of the Company are responsible for the release of this announcement.
ENDS
Enquiries:
Macaulay Capital PLC |
|
Clive Milner |
+44 (0)20 3946 5980 |
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
|
Louise O'Driscoll/Sandy Jamieson
|
+44 (0)20 7213 0880 |
Oberon Capital (Broker) |
|
Chris Crawford |
+44 (0)20 3179 5304 |
For more information please visit: www.macaulaycapital.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.